Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis.
Journal: Clinical and experimental gastroenterology
Published: February 05, 2014
TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: January 01, 2014
Showing 1-2 of 2
Last Updated: 09/26/2026